Eli Lily Recruiting for Phase 2 Trial to Test LY3154207 for Parkinson’s Dementia
Eli Lilly is recruiting patients for its Phase 2 clinical trial evaluating LY3154207 as a potential treatment for Parkinson’s…
Articles by Marta Figueiredo, PhD
Voice-Based Technology to Detect Mental, Physical Disorders Receives US, Australian Patents
Sonde Health’s vocal biomarker technology being developed to potentially diagnose and monitor mental and physical disorders, including Parkinson’s…
Herantis Creates Video to Show How Its Parkinson’s Therapy Works
Herantis Pharma has created an educational video about the way its Parkinson’s treatment CDNF works. The explainer comes as the…
New Software May Help Detect Early Parkinson’s Motor Signs At Home
Researchers have validated a software that evaluates typing patterns with keyboards to detect Parkinson’s disease-specific motor impairment. This approach, done in…
GeneFo’s Guide Can Help Parkinson’s Patients Apply for Medical Cannabis
GeneFo has created a free state-by-state guide for Parkinson’s patients with detailed and relevant information on medical cannabis, including the…
New Tremor Suppression Glove May Help Parkinson’s Patients Regain Motor Control
Researchers at Western University in Canada have developed a prototype of a new tremor suppression glove that may help people cope…
Nuplazid and Clozaril Are Most Reliable Parkinson’s Psychosis Therapies, Review Finds
The antipsychotics Nuplazid (pimavanserin) and Clozaril (clozapine) are the only therapies shown to improve Parkinson’s disease psychosis (PDP) symptoms without impairing motor…